Progestin & Progesterone belong to the progestogen class of steroid hormones. They are available both as natural and synthetic steroid hormones. Progesterone is a natural female hormone. Progesterone is also called pregnancy hormone and is the most important progestogen in the body. Progesterone are endogenous steroids secreted by corpus luteum, produced during the second half of menstrual cycle. Their main functions are the regulation of the menstrual cycle, embryogenesis, and maintenance of pregnancy. Low level of progesterone may result in miscarriage or fetal demise. Progesterone is used with estrogen as a hormone replacement therapy for the treatment of menopause in women. Progestin is a synthetic form of progesterone and is used in hormonal birth control and menstrual cycle. Progestin is available as oral tablets, intramuscular injections, and in solution forms. Progestin has similar functions to those of natural progesterone, but they are structurally different. Progestin are available under a brand names, Aygestin, Camila, Crinone, Errin, Prometrium, etc. Progestin are used worldwide and are contained in all birth control pills.
The global progestin & progesterone market is expected to show promising growth in the next few years because of their advanced way of treatment. Rise in incidence of Amenorrhea, which is the absence of menstrual periods, and increase in cases of infertility treatment in women, uterine dying, breast cancer, etc. are driving the global progestin & progesterone market. In combination with estrogen, progesterone is used as a hormone replacement therapy in the treatment of menopausal issues. Demand for progesterone is driven by the efficacy of progesterone in reducing breast pain and in the treatment of uterine tumor and other indications. Synthetic progesterone are used in the treatment of various indications. Other factors driving the growth of the progestin & progesterone market are increasing funding initiatives, rising trend of home health care, and infrastructure development in the health care industry across the globe. However, lack of awareness regarding accessibility of progestin & progesterone is restraining the growth of the market. Certain side-effects, such as, severe breast pain, blurred vision, vaginal bleedings, joint pains, headaches, dizziness, convulsions, and constipations pose major challenges to the progestin & progesterone market. Nevertheless, key players foresee opportunities to invest in the progestin & progesterone market due to the effective results produced by their application.
The global progestin & progesterone market can be segmented based on application, route of administration, distribution channels, and others. Based on application, the market can be classified into hormone therapy, pregnancy support, premenstrual syndrome, contraception, fertility support, breast cancer, and gynecological disorders. In terms of route of administration, the progestin and progesterone market can be divided into oral, injectable, and others. Progestin and progesterone are also available as capsules, tablets, gel, and others. Based on distribution channel, the progestin & progesterone market caters to hospital pharmacies, online pharmacies, and retail pharmacies. In terms of region, the global progestin & progesterone market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the global progestin & progesterone market owing to rising consumption of progestin & progesterone, increasing incidences of menstrual cycle issues, hormonal replacement, lifestyle disorders, and technological advancement. North America is followed by Asia Pacific and Europe, in terms of leading the global progestin & progesterone market. Asia Pacific is likely to be the fastest growing market for progestin & progesterone in the near future owing to increasing prevalence of chronic diseases and infertility in the region.
Major players operating in the global progestin & progesterone market include Pfizer Inc., GlaxoSmithKline plc, Solvay, Merck KGaA, ALLERGAN, Sanofi, Kaitai Hormone, Teva pharmaceuticals Industries Ltd., Zhejiang Xianju Pharmaceutical Co Ltd., and Chenggu Zhenhua Bio-Tech.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.